Showing results (671-680 of 702) with videos related to
Sort By:
Pageof 71
Acta Pharmacologica Sinica|June 28, 2024
Oncoprotein LAMTOR5-mediated CHOP silence via DNA hypermethylation and miR-182/miR-769 in promotion of liver cancer growthXue Wang, Qian-Qian Li, Yan-Xin Tang, et al.Gastroenterology|April 9, 2025
Metabolic Dysfunction-Associated Steatohepatitis Adipose Tissue Macrophages Secrete Extracellular Vesicles That Activate Liver Fibrosis in Obese Male MiceTheresa V Rohm, Felipe Castellani Gomes Dos Reis, Karina Cunha E Rocha, et al.American Journal of Hematology|May 22, 2025
A Phase 2 Trial of CPX-351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaTapan M Kadia, Wei-Ying Jen, Alex Bataller, et al.Nature|July 1, 2026
Heat-triggered phospholipid flipping stabilizes plasma membrane fluidityShijun Fan, Peng Gao, Kailai Huang, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2010
Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in miceYun Shi, Xiao-Fei Liu, Yuan Zhuang, et al.Mabs|October 27, 2018
Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft modelsWei-Ying Kuo, Hung-Ju Hsu, Chun-Yi Wu, et al.Blood Neoplasia|September 22, 2025
Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1Courtney D DiNardo, Wei-Ying Jen, Guillermo Montalban-Bravo, et al.Journal of Cancer Research and Clinical Oncology|July 8, 2019
A randomized phase II, open-label and multicenter study of combination regimens of bortezomib at two doses by subcutaneous injection for newly diagnosed multiple myeloma patientsFeng Li, Fu-Sheng Yao, Xi-Jun Zhu, et al.Nature Communications|January 4, 2024
Spin-related Cu-Co pair to increase electrochemical ammonia generation on high-entropy oxidesShengnan Sun, Chencheng Dai, Peng Zhao, et al.Hypertension (Dallas, Tex. : 1979)|April 7, 2021
Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin)Wei Ying, Kechun Tang, Ennio Avolio, et al.Pageof 71